Anpac Bio Medical Performance
The firm shows a Beta (market volatility) of 0.0, which signifies not very significant fluctuations relative to the market. the returns on MARKET and Anpac Bio are completely uncorrelated.
Risk-Adjusted Performance
Weakest
Weak | Strong |
Over the last 90 days Anpac Bio Medical has generated negative risk-adjusted returns adding no value to investors with long positions. In spite of rather sound basic indicators, Anpac Bio is not utilizing all of its potentials. The current stock price tumult, may contribute to shorter-term losses for the shareholders. ...more
Anpac |
Anpac Bio Relative Risk vs. Return Landscape
If you would invest (100.00) in Anpac Bio Medical on November 19, 2025 and sell it today you would earn a total of 100.00 from holding Anpac Bio Medical or generate -100.0% return on investment over 90 days. Anpac Bio Medical is currently does not generate positive expected returns and assumes 0.0% risk (volatility on return distribution) over the 90 days horizon. In different words, 0% of stocks are less volatile than Anpac, and 99% of all traded equity instruments are projected to make higher returns than the company over the 90 days investment horizon. Expected Return |
| Risk |
Anpac Bio Alerts and Suggestions
In today's market, stock alerts give investors the competitive edge they need to time the market and increase returns. Checking the ongoing alerts of Anpac Bio for significant developments is a great way to find new opportunities for your next move. Suggestions and notifications for Anpac Bio Medical can help investors quickly react to important events or material changes in technical or fundamental conditions and significant headlines that can affect investment decisions.| Anpac Bio Medical is not yet fully synchronised with the market data | |
| Anpac Bio Medical has some characteristics of a very speculative penny stock | |
| Anpac Bio Medical has a very high chance of going through financial distress in the upcoming years | |
| Anpac Bio Medical currently holds 19.81 M in liabilities with Debt to Equity (D/E) ratio of 1.44, which is about average as compared to similar companies. Anpac Bio Medical has a current ratio of 0.38, indicating that it has a negative working capital and may not be able to pay financial obligations when due. Note, when we think about Anpac Bio's use of debt, we should always consider it together with its cash and equity. | |
| The entity reported the previous year's revenue of 12.04 M. Net Loss for the year was (103.6 M) with profit before overhead, payroll, taxes, and interest of 12.25 M. | |
| Anpac Bio Medical currently holds about 462 K in cash with (55.06 M) of positive cash flow from operations. This results in cash-per-share (CPS) ratio of 0.02. |
Anpac Bio Price Density Drivers
Market volatility will typically increase when nervous long traders begin to feel the short-sellers pressure to drive the market lower. The future price of Anpac Stock often depends not only on the future outlook of the current and potential Anpac Bio's investors but also on the ongoing dynamics between investors with different trading styles. Because the market risk indicators may have small false signals, it is better to identify suitable times to hedge a portfolio using different long/short signals. Anpac Bio's indicators that are reflective of the short sentiment are summarized in the table below.
| Common Stock Shares Outstanding | 1.9 M | |
| Cash And Short Term Investments | 1.9 M |
Anpac Bio Fundamentals Growth
Anpac Stock prices reflect investors' perceptions of the future prospects and financial health of Anpac Bio, and Anpac Bio fundamentals are critical determinants of its market performance. Overall, investors pay close attention to revenue and earnings growth, profit margins, and debt levels. These fundamentals can have a significant impact on Anpac Stock performance.
| Return On Equity | -2.43 | |||
| Return On Asset | -0.53 | |||
| Operating Margin | (8.71) % | |||
| Current Valuation | 9.28 M | |||
| Shares Outstanding | 6.27 M | |||
| Price To Book | 5.67 X | |||
| Price To Sales | 0.41 X | |||
| Revenue | 12.04 M | |||
| EBITDA | (78.4 M) | |||
| Cash And Equivalents | 462 K | |||
| Cash Per Share | 0.02 X | |||
| Total Debt | 19.81 M | |||
| Debt To Equity | 1.44 % | |||
| Book Value Per Share | 10.63 X | |||
| Cash Flow From Operations | (55.06 M) | |||
| Earnings Per Share | (11.45) X | |||
| Total Asset | 40.47 M | |||
| Retained Earnings | (577.54 M) | |||
| Current Asset | 23.44 M | |||
| Current Liabilities | 68.22 M | |||
Things to note about Anpac Bio Medical performance evaluation
Checking the ongoing alerts about Anpac Bio for important developments is a great way to find new opportunities for your next move. Stock alerts and notifications screener for Anpac Bio Medical help investors to be notified of important events, changes in technical or fundamental conditions, and significant headlines that can affect investment decisions.| Anpac Bio Medical is not yet fully synchronised with the market data | |
| Anpac Bio Medical has some characteristics of a very speculative penny stock | |
| Anpac Bio Medical has a very high chance of going through financial distress in the upcoming years | |
| Anpac Bio Medical currently holds 19.81 M in liabilities with Debt to Equity (D/E) ratio of 1.44, which is about average as compared to similar companies. Anpac Bio Medical has a current ratio of 0.38, indicating that it has a negative working capital and may not be able to pay financial obligations when due. Note, when we think about Anpac Bio's use of debt, we should always consider it together with its cash and equity. | |
| The entity reported the previous year's revenue of 12.04 M. Net Loss for the year was (103.6 M) with profit before overhead, payroll, taxes, and interest of 12.25 M. | |
| Anpac Bio Medical currently holds about 462 K in cash with (55.06 M) of positive cash flow from operations. This results in cash-per-share (CPS) ratio of 0.02. |
- Analyzing Anpac Bio's financial statements, including its income statement, balance sheet, and cash flow statement, helps in understanding its overall financial health and growth potential.
- Getting a closer look at valuation ratios like price-to-earnings (P/E) ratio, price-to-sales (P/S) ratio, and price-to-book (P/B) ratio help in understanding whether Anpac Bio's stock is overvalued or undervalued compared to its peers.
- Examining Anpac Bio's industry or sector and how it is performing can give you an idea of its growth potential and how it is positioned relative to its competitors.
- Evaluating Anpac Bio's management team can have a significant impact on its success or failure. Reviewing the track record and experience of Anpac Bio's management team can help you assess the Company's leadership.
- Pay attention to analyst opinions and ratings of Anpac Bio's stock. These opinions can provide insight into Anpac Bio's potential for growth and whether the stock is currently undervalued or overvalued.
Check out Trending Equities to better understand how to build diversified portfolios. Also, note that the market value of any company could be closely tied with the direction of predictive economic indicators such as signals in employment. You can also try the Bonds Directory module to find actively traded corporate debentures issued by US companies.
Other Consideration for investing in Anpac Stock
If you are still planning to invest in Anpac Bio Medical check if it may still be traded through OTC markets such as Pink Sheets or OTC Bulletin Board. You may also purchase it directly from the company, but this is not always possible and may require contacting the company directly. Please note that delisted stocks are often considered to be more risky investments, as they are no longer subject to the same regulatory and reporting requirements as listed stocks. Therefore, it is essential to carefully research the Anpac Bio's history and understand the potential risks before investing.
| Price Ceiling Movement Calculate and plot Price Ceiling Movement for different equity instruments | |
| Idea Optimizer Use advanced portfolio builder with pre-computed micro ideas to build optimal portfolio | |
| Portfolio Dashboard Portfolio dashboard that provides centralized access to all your investments | |
| Transaction History View history of all your transactions and understand their impact on performance | |
| Commodity Channel Use Commodity Channel Index to analyze current equity momentum | |
| Stocks Directory Find actively traded stocks across global markets | |
| Pair Correlation Compare performance and examine fundamental relationship between any two equity instruments | |
| Sectors List of equity sectors categorizing publicly traded companies based on their primary business activities | |
| Options Analysis Analyze and evaluate options and option chains as a potential hedge for your portfolios |